Search

everythinglearnresearchcommunity

for

Search:↓

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

The hydrogel effectively treats hair loss using light to release nitric oxide.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

AH-001 could be a safer and more effective treatment for hair loss.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Blocking GPR91 can help prevent and reverse hair loss in androgenetic alopecia.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Notopterygii rhizoma et radix (Qiang Huo) can effectively treat psoriasis by reducing skin symptoms and inflammation.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Thyroid receptor β can help develop new drugs to treat hair loss.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.